By Gabriel Olawale
INDIAN High Commissioner in Nigeria, Mr. Abhay Thakur has assured of genuine collaboration in developing the local pharmaceutical production industry in Nigeria to meet the need of its timing population and boost the internally- generated revenue.
Speaking at the iPHEX 2019 organised by Pharmaceuticals Export Promotion Council of India, PHARMEXCIL, Thakur said that manufacturers of pharmaceutical products in India are willing to partner with Nigeria to develop its local production and show the rest of the world example of the best way to bilateral relationship.
“We will be glad to share our database with Nigeria and I have urged Indian community to help Nigeria in developing its manufacturing industry so that they can achieve 70 per cent local production and 30 per cent export.
“This will help Nigeria reduce its huge medical bill and healthcare cost while at the same time reduce the burden of unemployment
Thakur, however, promised to look into the issue of visa so as to ensure and promote exchange of ideas. “We are aware that some people are having challenges going to India, this is as a result of security issue and I can assure you that it is going to be temporary.
Reacting to India’s gesture, the Director- General of NAFDAC, Prof. Mojisola Adeyeye expressed gratitude to the Indians for partnering with Nigeria in promoting local production.
“My mandate is very simple, to turn around the pharmaceutical import index. Presently, local manufacturing of pharmaceutical products stand at 30 per cent while import is 70 per cent. This is unacceptable and we are going to do everything to record improved local production to about 70 per cent.
“We want to build a strong bilateral relationship with regulators in India because unlike in Nigeria where you have central regulatory body, in India, each state has its own regulatory authority which makes it difficult. We are now trying to build a bilateral relationship so that they will let us know which companies are making bad drugs and that will be a very positive step.
“We are encouraging our own local manufacturers to partner with India. We are also using this opportunity to appeal to multinational companies that are sending products to Nigeria to partner with our local manufacturers,” she disclosed.
The Director-General of PHARMEXCIL, Mr. Udaya Bhaskar urged NAFDAC to expedite drug approval process within three months after submission of valid dossier and ensure faster analysis of samples within four to six weeks.
“We want administrative approval for product renewals with the payment of renewal fee within one month and recognition of plant approvals of stringent regulatory authorities.